Abstract
Since the discovery of the first strain in 1961 in England, MRSA, the most notorious multidrug-resistant hospital pathogen, has spread all over the world. MRSA repeatedly turned down the challenges by number of chemotherapeutics, the fruits of modern organic chemistry. Now, we are in short of effective therapeutic agents against MRSA prevailing among immuno-compromised patients in the hospital. On top of this, we recently became aware of the rise of diverse clones of MRSA, some of which have increased pathogenic potential compared to the classical hospital-associated MRSA, and the others from veterinary sources. They increased rapidly in the community, and started menacing otherwise healthy individuals by causing unexpected acute infection. This review is intended to provide a whole picture of MRSA based on its genetic makeup as a versatile pathogen and our tenacious colonizer.
Methicillin-resistant Staphylococcus aureus (MRSA) is an S. aureus that became resistant to β-lactam antibiotics by acquiring mecA gene on its chromosomal DNA [1]. MRSA was first isolated in 1960 in England [2], and became a worldwide epidemic since 1970s. At least three distinct genotypes of MRSA were present in the 1980s [1], and two of them are still prevalent in the world as multi-drug-resistant healthcare-associated MRSA (HA-MRSA) [3]. They acquired resistance to practically all the antibiotics introduced into clinical use in the past half century. They conquered even the 'last-resort' antibiotic vancomycin [4, 5]. On top of it, from the early 1990s, MRSA with non-multi-drug-resistance phenotype emerged from various countries of the world such as Australia [6, 7], the USA [8], and France [9]. These MRSA strains appeared to have emerged outside the hospital and designated community-associated (or acquired) MRSA (CA-MRSA). The year 2010 marked the 50th anniversary of our continuous struggle with MRSA. However, with an unexpected new surge of MRSA strains in both hospital and community, we are forced to fight an even bitterer fight with them. In this review, we describe the genetic feature of the organism to lay a basis for our future project to control MRSA.
S. aureus possesses several GIs on the chromosome. Figure 1A illustrates comparison of the genome structures of 14 S. aureus strains. All open reading frames (orfs) identified on their chromosomes are shown as vertical lines, in which 1887 (denoted by grey lines) are commonly shared by the 14 strains. Red lines indicate the orfs that are not present in all the strains. On each chromosome there are regions where grey lines are sparse and red lines predominate. Those regions correspond to GIs. The genes essential for the life of bacteria are all included in the grey orfs. In contrast, GIs include genes associated with virulence or useful genes for some specific environmental challenges (e.g. drug-resistance gene), which presumably were acquired from other organisms by horizontal gene transfer. These S. aureus GIs include integrated prophages, oriC environ (discussed later) and νSa islands (ν stands for island) [10]. The S. aureus GIs are mostly comprised of exogenous genes acquired by intra-species gene transfer [11]. Since S. aureus is by far the most virulent among various staphylococcal species, the GIs contain many virulence genes such as tsst-1 encoding toxic shock syndrome toxin, and multiple enterotoxin (se) genes. There are two classes in the νSa islands: the first class is designated νSan where n is an Arabic numeral indicating the position in the S. aureus chromosome where it is localized. They correspond to the integration sites for the mobile pathogenicity islands of Staphylococcus (SaPI) and a mobile resistant island (SaRI) [12-14]. The latter nomenclature is based on the unique genetic structure common to these mobile genetic elements. Correlation of the two nomenclature systems is summarized in Table 1. As shown in Figure 1A, νSan classification refers to the location of the attachment site of the islands, and is correlated well with the evolutionary tree for the SaPI integrase gene (Fig. 1B).
The SaPI elements evolved themselves to take advantage of the bacteriophage as the vehicle for efficient intercellular transmission. A representative island, SaPI1, carrying tsst-1, possesses a packaging system for phage-mediated intercellular transfer [15]. Another island, SaPIbov1, is demonstrated to be carried by a small-sized bacteriophage head that infects S. aureus cell and transfer the island into one of the several attachment sites in the chromosome [16, 17]. SaRI has essentially the same structure with SaPI, but it carries a resistance gene to fusidic acid instead of virulence gene [14].
Another class of νSa islands is found on the S. aureus chromosome. They carry many virulence-related genes, but do not have apparent device for movements. Curiously, however, a remnant of a transposase gene whose putative intact form is found in the genome of Macrococcus caseolyticus, a bacterial species sharing a common ancestor with staphylococcal species [18]. The islands νSaα, νSaβ, νSaγ, νSaδ, νSaε belong to this class of islands [10, 19], where νSaα contains a series of ssl (staphylococcal superantigen-like) genes [20, 21]; νSaδ, (previously designated νSaγ [22, 23], carries genes encoding exfoliative toxin D (ETD) and epidermal cell differentiation inhibitor (EDIN); and νSaε carries accessory gene regulators T and U involved in the virulence regulation [24], and gene clusters encoding putative lipoproteins and fibronectin-binding proteins.
Figure 2 illustrates chromosomal localization of the orfs conserved across four staphylococcal species S. aureus, S. epidermidis, S. haemolyticus and S. saprophyticus. It shows that the order of the conserved orfs (synteny) is much more retained among S. aureus strains as compared to that between the two S. epidermidis strains. This coincides with our overall impression that S. aureus has a rather conserved (or rigid) chromosome structure when compared with the other two staphylococcal species, S. epidermidis and S. haemolyticus. The chromosomes of the latter seem to be extremely labile [25, 26].
The region around the origin of replication (oriC: located at the center in the illustration) is noted to be sparse for conserved orfs across staphylococcal species. This indicates that the region consists of a high proportion of species-specific genes acquired during the evolution of each species. The diversity of the chromosome is more pronounced in the region to the right of oriC (oriC to +0.5 Mb) than that to the left of oriC (-0.3 Mb to oriC). This coincides with the presence of orfX to the right of oriC, which serves as an attachment site for staphylococcal cassette chromosome (SCC), a unique horizontal gene transfer vehicle of staphylococci (discussed later). The figure also shows that the region contain a number of orfs unique to each S. aureus strain (denoted by grey short vertical bars in Figure 2) presumably acquired by SCC-mediated gene transfer. We designated this region 'oriC environ' [11]. The genetic information accumulated in oriC environ would be used by the cell to produce a more fit strain to the niche of survival.
S. aureus genome contains several copies of insertion sequences (ISs) and transposons (Tns). However, the number of copies is limited, and many of them are inactive suffering from mutations or deletions [18]. In contrast, as many as 82 IS elements are found on the S. haemolyticus genome, and most of them are intact [11]. It is curious why the number of IS or Tn are significantly different across staphylococcal species. It is well known that IS turns off a gene function by disrupting it or by inserting itself to the proximity of the target gene (polar effect) [27]. It can also up-regulate a gene transcription by integrating itself to the upstream region of a gene and providing it with a strong promoter activity [28]. In a sense, keeping many intact copies of IS and/or transposons on a chromosome is to keep the chromosome 'soft'. It is advantageous for the survival of such species of bacteria that are frequently exposed to challenging environmental conditions. The genome plasticity of S. haemolyticus is reflected in our rather frequent encounter with difficult-to-speciate clinical S. haemolyticus strains with their abnormal biochemical features compared to the standard S. haemolyticus strain [11]. Extremely high genome plasticity of S. haemolyticus might have made the species the first one to acquire vancomycin resistance [29]. It is also demonstrated that IS256 is more frequently found in nosocomial methicillin-resistant S. epidermidis (MRSE) isolates associated with septicemia and urinary tract infections as compared to commensal S. epidermidis isolates from healthy volunteers [30]. Consistent with this observation is that an oxacillin-susceptible S. epidermidis type strain ATCC12228 does not possess IS256 on the chromosome, whereas MRSE strain RP62A possesses 5 copies of IS256. Historically S. epidermidis was next only to S. haemolyticus to acquire intermediate vancomycin resistance [29]. Aside from spontaneous mutation as will be described below, IS256-mediated genome alteration might also contribute to the acquisition of vancomycin resistance in the two staphylococcal species.
In contrast to the human pathogenic staphylococci, a nonpathogenic staphylococcal species S. carnosus does not have any insertion sequences [31]. The species is isolated from meat products, and has been used safely since the 1950s as a starter culture for the fermentation of dry sausage. In the well-controlled nutrient-rich culture condition, the species would not need to alter the genome composition. So, it is reasonable that it does not maintain mobile genetic elements in the chromosome [31].
As described above, the oriC environ is a region around the oriC where multiple exogenous genes are accumulated as a result of repeated horizontal gene transfer events. It contains a number of DNA fragments of various sizes, flanked by characteristic direct repeats (DRs). They are designated staphylococcal cassette chromosomes (SCCs) [32, 33], and are integrated in tandem in the downstream region of orfX. The DR contains integration site sequence (ISS) for SCC, which is recognized by cassette chromosome recombinase (CCR). CCR mediates integration into and precise excision of SCC from chromosome [33]. The orfX is an orf of unknown function located near oriC but well conserved among diverse gram-positive bacteria. SCC carries various exogenous genes that are considered to confer certain growth or survival advantages to the host cell. As we saw in Figure 2, the oriC environ contains many species-, and strain-specific genes. It is probable that successive integration of SCC formed the oriC environ equipped with useful genes to adapt to an unfriendly environment, and thereby contributed to the evolution of new staphylococcal strains or species.
However, the oriC environ is not a mere storehouse of foreign genes. It has another function as an extremely active diversifier of chromosome. The oriC environ serves as the generator of diversity by accumulating foreign genes, deleting useless or hazardous ones, and event inverting large chromosomal fragments across the oriC. This process is achieved by the chromosome shuffling mediated by IS and Tn copies abundantly found in oriC environ [26].
Search for the genetic determinant of methicillin resistance (mec) has a long history. In 1975, Sjöström et al. demonstrated localization of mec on the MRSA chromosome [34]. In 1978 Kuhl et al. mapped mec in the linkage group II pyr-his-nov-pur of MRSA chromosome [35]. In 1980, Stewart and Rosenblum demonstrated that mec is localized on a chromosomal region (designated 'additional DNA') of MRSA, which is absent from MSSA chromosome [36]. In the early 1980s, using the penicillin-binding assay of PBP researchers noticed that a novel low-affinity penicillin-binding protein designated PBP2' or PBP2a (MecA) is produced by MRSA [37-40]. The gene mecA encoding MecA was subsequently cloned by Matsuhashi et al. by using a physically-linked tobramycin resistance determinant as a marker for cloning [41].
Matsuhashi et al. observed that mecA gene was linked to the nucleotide sequence similar to the promoter and truncated homolog of the regulator gene blaR1 of beta-lactamase (bla)-gene complex. The intact bla-gene complex has the structure blaI-blaR1-(p)-blaZ, where p stands for the divergent promoters for blaZ and blaR1. Since mecA was found in the structure ΔblaR1-(p)-mecA, they proposed the idea that mec-gene complex was produced by recombination event between mecA gene and bla-gene complex, by homologous recombination [42]. The blaI and blaR1 genes encode repressor and membrane-bound signal transducer, respectively, of blaZ transcription. Therefore, it was predictable that the integrated mecA gene in the place of blaZ was under regulatory control of the bla regulator genes. However, the strain which Matsuhashi used for molecular cloning did not contain an intact set of regulator genes. Tesch et al. was the first demonstrating the presence of the region (called mecR locus) upstream of mecA of methicillin-resistant S. epidermidis strain WT55 that strongly repressed expression of MecA [43].
There were methicillin-resistant strains with and without the mecR locus [44, 45]. Those having the mecR locus tend to be slow in the induced production of MecA by exposure to methicillin [46]. We also identified the mecR locus in S. aureus strain N315 that was curiously methicillin-susceptibile irrespective of the presence of mecA gene. The mecI-mecR1 regulator genes homologous to blaI-blaR1 were found in the mecR locus of N315 [47]. Inactivation of mecI gene de-repressed production of MecA, and induced expression of methicillin resistance [48]. The mecA gene transcription is also repressed by bla-gene complex on a plasmid harbored by N315, but the bla regulators allowed much quicker induction of mecA on exposure to methicillin. As expected, mecI gene was either deleted or mutated in most of the clinical MRSA isolates having apparent methicillin-resistant phenotype [1]. There were also some strains with intact mecI gene but having a mutation in the operator region of mecA gene to which MecI repressor protein is supposed to bind [1]. The mecA-carrying methicillin-susceptible strains as N315 are rarely found in clinical samples. It is consistent with the observation that N315 generates mecI-inactivated mutants at high frequencies upon beta-lacatm selection in vitro. Such strain as N315 having depressed MecA expression due to the intact mecI was considered as a precursor of MRSA, designated pre-MRSA [1, 48].
Using three epidemiologically representative MRSA strains with different genetic backgrounds, we determined the nucleotide sequence of entire additional DNAs [1, 49]. They appeared as long (32->60 Kb) stretches of chromosomal DNA regions with many orfs of unknown function within which two important clusters of genes were identified; mec-gene complex (encoding methicillin resistance) and cassette chromosome recombinase (ccr) -gene complex (encoding one or two site-specific recombinases for the movement of the element) [50] (Fig. 3A). These long DNA regions were found integrated site-specifically at the integration site sequence (ISS) present at the 3' end of orfX as if it were a 'cassette' DNA. We designated the element staphylococcal cassette chromosome mec (SCCmec) [33]. However, unlike the refined image of the 'cassette' for integron [51], SCCmec elements were much larger and studded with apparently useless pseudogenes or truncated copies of transposons and insertion sequences. This is the reason why the authors called the regions around the two essential gene clusters as J (standing for 'junkyard') regions [52]. Now, the J region is spelt out as 'joining' and its sequence is used for the subtyping of various SCCmec types [53, 54].
As illustrated in Figure 3A, SCCmec is demarcated by specific inverted repeats (IR) and direct repeats (DR) that contain integration site sequence acted on by cassette chromosome recombinase (CCR). The element carries the mecA gene, as a component of mec-gene complex, and ccr gene(s) (ccrAB or ccrC) that encode CCR(s). The integration site for the cassette chromosome is present at the 3'-end of an open reading frame, orfX. As a result of integration, the SCC element is flanked by a couple of direct repeat (DR) sequences, both of which serve as integration sites for the next SCC element (Fig. 3A). The function of orfX is unknown, but it may encode an important protein. Upon integration of SCCmec, 15 bp of the 3'-end of orfX are replaced by the terminal nucleotide sequence of the integrated SCCmec. Curiously, however, in spite of the difference in the nucleotide sequence, the encoded peptide is unchanged before and after the integration of any type of SCCmec [49, 55, 56].
Many types of SCCmec have been found (Fig. 3B). At present, 11 types are registered [57], and more numbers are expected to be found in the future. The SCCmec type is defined by the combination of the type of ccr-gene complex and the class of mec-gene complex. Types I-III are older SCCmec types that are harbored by HA-MRSA [49]. They are relatively big in size and carry multiple antibiotic resistance determinants. Types IV and V were recognized as new versions of SCCmec that were almost diagnostically harbored by CA-MRSA [55, 56, 58]. They are short, and typically carrying no antibiotic resistance genes other than mec-gene complex. These new types of SCCmec are widely distributed among methicillin-resistant non-aureus staphylococci (MRNAS) especially among methicillin-resistant S. epidermidis (MRSE) carried by Japanese healthy children in the community [25, 59]. Recent study performed in other countries showed wide distribution of type-IV SCCmec among MRSE and type-V SCCmec in methicillin-resistant S. haemolyticus (MRSH) in the community [60]. These data indicate that MRNAS serves as the reservoir for horizontal gene transfer of new types of SCCmec to S. aureus.
Integration of SCCmec into the oriC environ of MSSA chromosome generates MRSA. Therefore, each clone of MRSA (clonotype) can be described by the combination of the genotype of recipient MSSA strain and the genotype of the integrated SCCmec [3, 50, 61]. Recent worldwide outbreak of community-acquired MRSA (CA-MRSA) is caused by the emergence of new molecular types of SCCmec [58]. MRSA carrying new types of SCCmec (types IV and V) appeared in the last decade and almost simultaneously from various countries in the world [55,56]. As shown in Figure 3B, types IV and V are discriminated from the previously dominant three types of SCCmec (mostly carried by HA-MRSA) with different combinations of mec-gene complex and ccr-gene complex. When compared with HA-MRSA strains with type I-III SCCmec, CA-MRSA strains carrying type-IV and type-V SCCmec tend to be faster in growth, more virulent, resistant to fewer antibiotic classes (non-multi-resistant), and lower in the degree of beta-lactam resistance (heterogeneously methicillin resistant) [58]. These features of CA-MRSA strains seem to be associated with the structural feature of the new types of SCCmec. The most evident first feature is the small size of the type -IV and -V SCCmec: they carry less number of exogenous genes that might disturb physiology of the cell, and no antibiotic resistance gene against various antibiotic classes besides mecA gene [58]. The smaller size of the elements might have helped them distribute in such an explosive way to community S. aureus strains by efficient horizontal gene transfer presumably via bacteriophages [62].
Another feature is observed with type-IVa SCCmec, which is widely disseminated in CA-MRSA [58]. All the eight type-IVa SCCmec elements so far sequenced share a mutation in the Shine-Dalgarno (S-D) sequences for mecA gene (they have -AGGAGT- instead of -AGGAGG-). This might explain the low phenotypic expression of methicillin resistance (or hetero-methicillin resistance) with oxacillin MIC values of 4-64 mg/L of the CA-MRSA strains carrying the type of SCCmec [58]. In most of the MRSA strains, the production of MecA encoded by mecA gene is repressed by BlaI repressor protein encoded by blaI gene on the penicillinase plasmid [63]. De-repressed expression of the exogenously acquired cell-wall synthesis enzyme MecA seems to cause disadvantage to the cell presumably by disturbing otherwise well organized cell-wall synthesis performed by multiple intrinsic enzymes. In fact, removal of penicillinase plasmid de-represses mecA gene expression and causes frequent loss of mecA gene during drug-free passage [64, 65]. Lee et al. also examined the cost of acquisition of SCCmec using an MSSA strain NCTC8325 (BB255) [66]. The doubling time of the MSSA strain was 39.3 min. The doubling time of the transformant with type-I SCCmec increased significantly to 54.5 min, whereas that with the type-IV SCCmec was 41.3 min. Moreover, type-IV SCCmec did not impose an energetic cost to its recipient MSSA with regard to the amount of the cell mass produced by consuming a unit of ATP. On the other hand, the presence of type-I SCCmec significantly reduced the cell yield [66]. Type-I SCCmec appears to have a negative effect on the growth rate and the effective cell reproduction compared to type-IV SCCmec in batch culture. The reason for this difference is yet to be examined, however, Lee et al. referred to the possible contribution of the mutated S-D sequence for mecA gene in the type-IV SCCmec used for the experiments [66]. Low expression of MecA due to the mutated S-D sequence may make the cell more fit in the survival in the community where exposure to beta-lactam antibiotics is less frequent than in the hospital.
The third intriguing feature of new SCCmec is the absence of psm-mec gene encoding phenol-soluble modulin [67]. It is present adjacent to the mecI gene of class-A mec-gene complex (Fig. 4). Although S. aureus is non-flagellated and unable to move, but some strains as MSSA strain Newman tend to spread on soft agar forming diffuse colonies [68]. Introduction of the psm-mec found in class-A mec gene complex into Newman suppressed its spreading ability and decreased exotoxin production. Introduction of psm-mec also attenuated the virulence of Newman in a murine systemic infection model [69]. Presence of psm-mec decreases the production of cytolysin PSMα. PSMα is another phenol-soluble modulin that augments cytokilling activity of Panton-Valentine leukocidin [70]. Both the transcription and translation products of the psm-mec suppressed colony-spreading activity and promoted biofilm formation [71]. This psm-mec RNA was found to bind agr mRNA and inhibit translation of the agrA gene [72]. Since agrA encodes a positive transcription factor for the psmα gene, the production of PSMα is depressed. The gene is found immediate downstream of mecI gene of type-II, type-III, and type-VIII SCCmec elements, whereas it is absent from type-IV and V SCCmec elements [69]. The absence of the gene from the new types of SCCmec explain at least partially the higher virulence of CA-MRSA strains as compared to HA-MRSA.
When SCCmec was found, it was considered that it is an exclusive vehicle for mec-gene complex and some other drug-resistance genes (Fig. 3B). Subsequently, however, SCCs harboring other functional genes than mecA started to be found in the oriC environ. They carried type-1 capsule gene cluster (SCCcap1) [73], fusidic acid resistance gene (SCCfur) [74], and mercury resistance operon (SCCHg) [53], penicillin-binding protein 4 [75], and enterotoxin H (seh) [10]. Recently, an SCC-like element carrying an arginine deiminase pathway and an oligopeptide permease system (designated arginine catabolic mobile element [ACME]) was found next to a type-IV SCCmec element in a CA-MRSA strain prevailing in the USA (designated USA300) [76]. The element is considered to confer better survival ability and increased virulence to the strain. With these observations, now it seems likely that SCC serves as a vehicle for not only drug resistance genes but also diverse genes useful for better adaptation to the unfriendly environment. Multiple SCC elements can be integrated sequentially into one of the DRs bracketing the previously integrated SCC elements. Thereby, accumulation of multiple SCC elements carrying various functions is achieved to allow diversification of S. aureus genome.
Search for the origin of mecA gene was an important project for the researchers of MRSA. First, a mecA gene homolog encoding a PBP with 88% amino acid similarity to MecA was found on the chromosome of S. sciuri strains [77]. Then a mecA gene homolog with practically identical nucleotide sequence (greater than 99%) with mecA was discovered on the chromsome of S. fleurettii [78], one of the oldest staphylococcal species. As shown in Figure 4, the chromosomal locus containing the complete mecA-gene complex as well as the surrounding J regions bracketed by two mobile genetic elements Tn554 and IS431 of type-II SCCmec was found in S. fleurettii strain SFMP07 [78]. Subsequent whole genome sequencing of the strain revealed that the region was about 240-Kb apart from the orfX, and there were multiple SCCs in the vicinity of orfX but no copy of it found around the mecA gene complex (Tsubakishita et al. in preparation). This indicated that mecA was an intrinsic component of the chromosome of S. fleurettii. It must have been an important PBP for the ancestral staphylococci to survive the environment soaked with ß-lactam antibiotics produced by fungi and Actinobacteria. The mecA gene must have been transmitted vertically during the initial steps of staphylococcal speciation. However, after a while, it became decayed (with mutations) or deleted out from the chromosomes of the descendants as exemplified by the emergence of methicillin-susceptible S. aureus (MSSA) as a human colonizer. It is curious why mecA gene was lost from the staphylococcal chromosome during speciation. The divergence time of S. sciuri group from the major staphylococcal clade including S. aureus is calculated to be 200-300 million years ago [79], which corresponds to the geological age of the emergence of mammalian animals. Since then, staphylococcal species evolved with mammalians as the colonizers of diverse mammalian animals [79]. Our hypothesis is that the descendants of staphylococci became methicillin-susceptible, because they became protected from the threat of ß-lactam-producing fungi or actinobacteria by the immune system of mammalian hosts [79].
SCC is a mobile genetic element found only in staphylococcal species and in macrococcal species that are close relatives of the former. The two genera share the same ancestor and diverged from each other about 300 million years ago as inferred by the phylogenetic tree with 16S and 23S DNA sequences and calculation based on the ecological distribution study of staphylococci across mammalian animals [79]. Genetic study on several ß-lactam-resistant Macrococcus caseolyticus strains isolated from China, Japan, and Thailand, revealed that they did not harbor mecA. Instead, a novel PBP designated mecB was identified on a plasmid, which turned out to be a distantly related mecA-gene homolog, and was shown to confer methcillin resistance on the cell. The gene had 61.7% of nucleotide identity with mecA (Fig. 5). The mecB was also accompanied by regulator genes mecR1b and mecIb that were also distantly related to the mecR1a (53.5% identity) and mecIa (60.2% identity), respectively, of the mecA-gene complex. Curiously, however, unlike mecA gene, mecB was accompanied by a blaZ homolog (blaZb) encoding a putative beta-lactamase. Moreover, unlike mecA-gene complex, the mecB-gene complex (blaZb-mecB-mecR1b-mecIb) was adjoined to transposase genes, forming transposon Tn6045 (Fig. 5). The mecB transposon was found on either plasmid (Fig. 6) or chromosome of macrococcal strains. One strain JCSC7096 harbored the transposon on the chromosome next to orfX, and an SCC element carrying ccrAB genes was found right next to the transposon [80]. Only one copy of the direct repeats of the transposon separated the two elements, Tn6045 and the SCC. A mere mutational inactivation of transposase or deletion of the direct repeat would be enough to combine the two elements into a new SCCmec [80]. The new SCCmec may come into the strains of staphylococci in near future, or might have already been there to be found by the researchers.
Recently, another mecA-gene homolog designated mecC was found on the chromosome of MRSA strains of animal as well as human sources [81, 82]. mecC was almost equally distant from mecA and mecB, and shared the characteristic gene order of blaZc-mecC-mecR1c-mecIc, having a blaZ-gene homolog next to mecC (Fig. 5). However, unlike mecB-gene complex, the mecC-gene complex was not associated with transposase genes. Instead, it was linked to ccr-gene complex forming a novel SCCmec (type XI; see Figure 3B). So far, mecC has also been found on the chromosome of S. xylosus [83], but mecB has yet to be found in staphylococcal species. A possible explanation for this difference might be due to the host specificity of the mobile genetic elements that carry them; mecA and mecC are carried by SCC, and mecB, by transposon. However, the plasmid carrying the mecB transposon seems to have a broad host range (Fig. 6). It is a resistance (R) plasmid carrying genes with diverse blast top-hit entries across several other bacterial genera besides Macrococcus and Staphylococcus. They cover more than 10 genera including Enterococcus, Bacillus, and Streptococcus (Fig. 6). It is speculated that mecB is provided to diverse bacterial genera via the plasmid. And yet, mecB has not been found in staphylococcal species. SCC may be a more efficient genetic transfer machinery than plasmid or transposon across staphylococcal species, although we do not know its inter-species transfer mechanism. It would be an important project to look for the vehicle of SCC transmission to reveal seemingly an efficient genetic information exchange system of staphylococcal species.
Figure 7 shows the evolutionary tree of penicillin-binding proteins (PBPs) of Staphylococcus species. S. aureus has four PBPs, and MRSA has MecA or MecC acquired by horizontal transfer as the fifth PBP. When the Macrococcus MecB was used for the homology search, other genera such as Enterococcus species were found to have mec gene homologs. The pbp homologs possessed by Macrococcus caseolyticus came between those of the enterococci and staphylococci in terms of the degree of homology. The MecA homologs with 83-90% amino acid (aa) identities were found in non-aureus staphylococcal species [77, 84]. With the discovery of the Macrococcus MecB having 52% aa identity to MecA, all the Mec homologs including recently identified MecC were grouped as members of the Mec superfamily together with a group of enterococcal PBPs (Fig. 7). This is a significant observation, because it has long been known that enterococcal species especially E. faecium is naturally resistant to beta-lactam antibiotics [85]. The degree of resistance as evaluated by beta-lactam MIC was well correlated with the degree of binding saturation of PBPs produced by enterococcal strains [86]. Thus the binding affinity of the PBPs and the amount of their production are considered to determine the level of susceptibility of the strain towards beta-lactam antibiotics. PBP5 of E. faecium was shown to have the lowest binding affinity to beta-lactam antibiotics. Similarity between MecA and enterococcal low-affinity PBPs was pointed out when mecA gene was cloned and sequenced [87]. By the way, a pbp gene was found on a plasmid harbored by a beta-lactam resistant Enterococcus hirae strain. The predicted protein encoded by the gene, designated PBP3r, had 99.7% amino acid identity to PBP5 of E. faecium [88]. Therefore, it seems likely that not only MecB but also other ß-lactam-insensitive pbp genes were valuable trade articles among bacterial species annoyed by ß-lactam-producing fungi or actinobacteria.
Figure 7 also reveals a curious fact that PBP4 is classified into two subgroups based on the Blast homology analysis. One group is named PBP4a that contains S. aureus PBP4, and the other, PBP4b to which Macrococcus PBP4 belongs (Fig. 7). Figure 8 shows the relative chromosomal locations and direction of transcription of the pbp genes on the macrococcal and staphylococcal chromosomes. The relative locations for pbps1-3 are well conserved among M. caseolyticus and four staphylococcal species. The location of pbp4a relative to pbps1-3 is conserved in several staphylococcal species. However, no pbp4 is found in S. epidermidis strain RP62A, and pbp4a is absent but pbp4b is present in another S. epidermids strain ATCC12228. Curiously, both pbp4 subtypes are present in S. haemolyticus strain JCSC1435 and S. carnosus strain TM300. It is also remarkable that, like mecA gene, most of the pbp4 genes are localized in the oriC environ (Fig. 8). The pbp4b of S. epidermidis strain ATCC12228 in Figure 8 was actually carried by an SCC element designated SCCpbp4 [89]. Therefore, it is likely that at least a part of pbp4 genes on staphylococcal species were acquired by horizontal gene transfer, whereas the set of three pbps1-3 were vertically transmitted from the common ancestor of macrococcal and staphylococcal species.
In the case of S. epidermidis strains, vertically transmitted pbp4a might have been lost from RP62A by chromosome shuffling in the oriC environ, and ATCC12228 acquired pbp4b homolog as an SCC element by horizontal gene transfer. PBP4 is not essential for the viability of S. aureus [90], but its overproduction raises resistance to beta-lactam antibiotics [91]. By functioning as a transpeptidase, PBP4 increases peptidoglycan cross linkage, giving the cell wall a more rigid structure. Therefore, like mecA, pbp4 seems to serve as a mobile pbp to aid ß-lactam resistance of staphylococcal and related bacterial species.
Acquisition and expression of mecA gene alone do not make the cell uniformly resistant to ß-lactam antibiotics. The expression of MecA confers on the bacterial strain a moderate level of resistance to ß-lactam antibiotics. The strain shows a unique pattern of antibiotic resistance called 'hetero-resistance'. Such MRSA is called hetero-MRSA. Figure 9 shows a typical ß-lactam (methicillin)-resistance profile of a hetero-MRSA (strain N315ΔIP) to which 64 mg/L of methicillin is effective to suppress the growth of 99.9% of N315ΔIP (Fig. 9). However, the rest of the cell population does grow. The population is composed of heterogeneous subpopulations of cells with higher methicillin resistance in different degrees. Figure 9 shows that a minor subpopulation of N315ΔIP consisting about one in 1 million part of the entire cell population can grow even in the presence of 1,024 mg/L of methicillin (Fig. 9). Exposure of the hetero-MRSA strain to a potent ß-lactam such as imipenem easily selects out a mutant strain, whose entire cell population is uniformly highly resistant to ß-lactam antibiotics, called homogeneously methicillin-resistant S. aureus (homo-MRSA) [61, 92]. This change, designated 'hetero-to-homo conversion' of ß-lactam resistance, is achieved by spontaneous mutations on the chromosome designated chr* [93].
So far mutations in vraSR (standing for vancomycin resistance sensor and response regulator) [94, 95], a two-component regulator system for S. aureus cell-wall synthesis, have been identified as chr*. Mutations vraS (H5N) and vraS (S329L) constitutively activate the regulatory system, and enhance cell-wall synthesis of the cell. Concomitant increase in resistance was observed against cell-wall synthesis inhibitor antibiotics such as ß-lactam, fosfomycin, bacitracin, and glycopeptides [94].
Now, extensive search for chr* can be done using high thorough-put whole genome sequencing strategy. By comparing the genome of hetero-MRSA strain ΔIP and its derivative strain ΔIP-H5, a mutant strain obtained by selection of ΔIP with imipenem, we found a mutation rpoB (N967I) as a chr* for the hetero-to-homo conversion of MRSA [96]. Likewise, another mutation rpoB (R644H) was identified from a N315-derived strain N315h4 expressing 'Eagle-type' methicillin resistance [97]. Eagle type resistance has a unique population analysis curve as illustrated in Figure 9: more cells grow in the presence of higher concentrations of methicillin (32-256 mg/L) than in low concentrations (4 and 8 mg/L). Eagle-type resistance is known to be a special phenotypic expression of chr* in the 'pre-MRSA' strain N315 in which mecA gene expression is strongly repressed under the repressor function of mecI gene [48]. Since induction of mecA gene transcription by low concentrations of methicillin is weak and slow in pre-MRSA, cells die. The rpoB mutations seem to confer on the cell methicillin 'tolerance', and allow the cell survive in methicillin until enough amount of MecA is accumulated in the cell [48, 96].
rpoB gene encodes RNA polymerase ß subunit RpoB. Mutation of rpoB has long been assigned significance only as the resistance marker for rifampin. Recently however, we started to notice that rpoB mutations affect various antibiotics other than rifampin (Fig. 10). One of the most frequent mutations rpoB(H481Y) raises not only rifampin resistance but also vancomycin-intermediate resistance of S. aureus [98]. Another mutation rpoB (Q468K) raises resistance to both rifampin and daptomycin. Mutations rpoB (T480M) and rpoB (R503H) do not affect rifampin susceptibility, and yet raise resistance to teicoplanin, vancomycin, and daptomycin [98]. The two mutations rpoB (N967I) and rpoB (R644H) do not affect susceptibility to rifampin either, but cause hetero-to-homo conversion of methicillin resistance (Fig. 10) [96]. Curiously, practically all rpoB mutations so far identified conferred enhanced susceptibility to linezolid [98].
Depending on the locations of the mutations in rpoB gene and the kinds of amino acid substitutions the repertoire of affected antibiotics and the degrees of resistance are different [98]. Matsuo et al. showed that the resistant subpopulations of heterogeneously vancomycin-intermediate S. aureus (hVISA) contain the cells with many different rpoB mutations [98]. hVISA and hetero-MRSA share a similar population analysis curve. Therefore, it is likely that rpoB mutations are one of the major classes of mutations that determine the characteristic shape of the population curve of both hetero-MRSA and hVISA (Fig. 9).
rpoB mutations are well known to cause rifampin resistance by changing the conformation of the rifampin-binding site of RpoB. However, there are another class of rpoB mutations that decrease susceptibility to such antibiotics as glycopeptides, ß-lactam, and daptomycin without affecting rifampin susceptibility. RpoB is not the target of these antibiotics. Therefore, those rpoB mutations are considered to change the antibiotic susceptibility of the cell indirectly by changing the physiology of the cell. In this sense, those rpoB mutations are regarded as 'regulatory mutations'. They confer changes in transcription profile of the cell by altering the interaction preferences of RNA polymerase holoenzyme for diverse transcription regulator proteins.
Now, with a great technical advance in high thorough-put determination of nucleotide sequence, it became easy to determine and compare hundreds of bacterial genomes. By doing this, we will obtain a bird's view of the evolution of life on the earth. Antibiotic chemotherapy has long been faced with a difficult problem of antibiotic resistance. It is now evident that no antibiotic can escape the doom of emergence of resistance. As we have seen, however, methicillin resistance is likely to have existed long before the advent of mammalians in the history of life. We may reasonably think that antibiotic resistance is not an outcome of human misconduct. Apparent vicious cycle of antibiotic and antibiotic resistance may be regarded as a providence of nature. We recently found a curious class of antibiotic designated Reverse Antibiotic (RA), which was active against quinolone-resistant S. aureus but inactive against quinolone-susceptible S. aureus [99]. RA was found in the soil of earth as a natural product. It is futile to try to disrupt the vicious cycle by incessantly producing new antibiotics. Instead, we may learn how to control the procession of the vicious cycle by closely observing the life history of earth, where all the opponent microorganisms seem to coexist in a dynamic equilibirium.
Acknowledgement
We thank Dr Ikuo Uchiyama for his help in the computer analysis of orthologous orfs conserved across bacterial species. This study was supported by Grant-in-Aid for (S1201013) from MEXT (Ministry of Education, Culture, Sports, Science and Technology) - Supported Program for the Strategic Research Foundation at Private Universities, 2012 - 2017.
References
2. Jevons MP. 'Celbenin'-resistant staphylococci. BMJ. 1961; 1:124–125.
3. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A. 2002; 99:7687–7692. PMID: 12032344.
4. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother. 1997; 40:135–136. PMID: 9249217.
5. Chang S, Sievert DM, Hageman JC, Boulton ML, Tenover FC, Downes FP, Shah S, Rudrik JT, Pupp GR, Brown WJ, Cardo D, Fridkin SK. Vancomycin-Resistant Staphylococcus aureus Investigative Team. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003; 348:1342–1347. PMID: 12672861.
6. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect. 1993; 25:97–108. PMID: 7903093.
7. Riley TV, Pearman JW, Rouse IL. Changing epidemiology of methicillin-resistant Staphylococcus aureus in Western Australia. Med J Aust. 1995; 163:412–414. PMID: 7476610.
8. Moreno F, Crisp C, Jorgensen JH, Patterson JE. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis. 1995; 21:1308–1312. PMID: 8589164.
9. Aubry-Damon H, Legrand P, Brun-Buisson C, Astier A, Soussy CJ, Leclercq R. Reemergence of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus: roles of an infection control program and changes in aminoglycoside use. Clin Infect Dis. 1997; 25:647–653. PMID: 9314454.
10. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002; 359:1819–1827. PMID: 12044378.
11. Takeuchi F, Watanabe S, Baba T, Yuzawa H, Ito T, Morimoto Y, Kuroda M, Cui L, Takahashi M, Ankai A, Baba S, Fukui S, Lee JC, Hiramatsu K. Whole-genome sequencing of Staphylococcus haemolyticus uncovers the extreme plasticity of its genome and the evolution of human-colonizing staphylococcal species. J Bacteriol. 2005; 187:7292–7308. PMID: 16237012.
12. Lindsay JA, Ruzin A, Ross HF, Kurepina N, Novick RP. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol. 1998; 29:527–543. PMID: 9720870.
13. Novick RP, Subedi A. The SaPIs: mobile pathogenicity islands of Staphylococcus. Chem Immunol Allergy. 2007; 93:42–57. PMID: 17369699.
14. O'Neill AJ, Larsen AR, Skov R, Henriksen AS, Chopra I. Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus. J Clin Microbiol. 2007; 45:1505–1510. PMID: 17344365.
15. Ubeda C, Maiques E, Tormo MA, Campoy S, Lasa I, Barbé J, Novick RP, Penadés JR. SaPI operon I is required for SaPI packaging and is controlled by LexA. Mol Microbiol. 2007; 65:41–50. PMID: 17581119.
16. Tormo MA, Ferrer MD, Maiques E, Ubeda C, Selva L, Lasa I, Calvete JJ, Novick RP, Penadés JR. Staphylococcus aureus pathogenicity island DNA is packaged in particles composed of phage proteins. J Bacteriol. 2008; 190:2434–2440. PMID: 18223072.
17. Chen J, Novick RP. Phage-mediated intergeneric transfer of toxin genes. Science. 2009; 323:139–141. PMID: 19119236.
18. Baba T, Kuwahara-Arai K, Uchiyama I, Takeuchi F, Ito T, Hiramatsu K. Complete genome sequence determination of a Macrococcus caseolyticus strain JSCS5402 reflecting the ancestral genome of the human pathogenic staphylococci. J Bacteriol. 2009; 191:1180–1190. PMID: 19074389.
19. Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, Paulsen IT, Kolonay JF, Brinkac L, Beanan M, Dodson RJ, Daugherty SC, Madupu R, Angiuoli SV, Durkin AS, Haft DH, Vamathevan J, Khouri H, Utterback T, Lee C, Dimitrov G, Jiang L, Qin H, Weidman J, Tran K, Kang K, Hance IR, Nelson KE, Fraser CM. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J Bacteriol. 2005; 187:2426–2438. PMID: 15774886.
20. Lina G, Bohach GA, Nair SP, Hiramatsu K, Jouvin-Marche E, Mariuzza R. International Nomenclature Committee for Staphylococcal Superantigens. Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis. 2004; 189:2334–2336. PMID: 15181583.
21. Langley R, Wines B, Willoughby N, Basu I, Proft T, Fraser JD. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol. 2005; 174:2926–2933. PMID: 15728504.
22. Baba T, Takeuchi F, Kuroda M, Ito T, Yuzawa H, Hiramatsu K. The Staphylococcus aureus genome. In : Ala'Aldeen D, Hiramatsu K, editors. Staphylococcus aureus Molecular and Clinical Aspects. Chichester, UK: Horwood Publishing;2004. p. 66–153.
23. Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M. Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B. Infect Immun. 2002; 70:5835–5845. PMID: 12228315.
24. Manna AC, Cheung AL. sarU, a sarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus. Infect Immun. 2003; 71:343–353. PMID: 12496184.
25. Jamaluddin TZ, Kuwahara-Arai K, Hisata K, Terasawa M, Cui L, Baba T, Sotozono C, Kinoshita S, Ito T, Hiramatsu K. Extreme genetic diversity of methicillin-resistant Staphylococcus epidermidis strains disseminated among healthy Japanese children. J Clin Microbiol. 2008; 46:3778–3783. PMID: 18832123.
26. Watanabe S, Ito T, Morimoto Y, Takeuchi F, Hiramatsu K. Precise excision and self-integration of a composite transposon as a model for spontaneous large-scale chromosome inversion/deletion of the Staphylococcus haemolyticus clinical strain JCSC1435. J Bacteriol. 2007; 189:2921–2925. PMID: 17237177.
27. Gustafson J, Strässle A, Hächler H, Kayser FH, Berger-Bächi B. The femC locus of Staphylococcus aureus required for methicillin resistance includes the glutamine synthetase operon. J Bacteriol. 1994; 176:1460–1467. PMID: 7509336.
28. Maki H, Murakami K. Formation of potent hybrid promoters of the mutant llm gene by IS256 transposition in methicillin-resistant Staphylococcus aureus. J Bacteriol. 1997; 179:6944–6948. PMID: 9371438.
29. Hiramatsu K. Vancomycin resistance in staphylococci. Drug Resist Updat. 1998; 1:135–150. PMID: 16904400.
30. Kozitskaya S, Cho SH, Dietrich K, Marre R, Naber K, Ziebuhr W. The bacterial insertion sequence element IS256 occurs preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilm formation and resistance to aminoglycosides. Infect Immun. 2004; 72:1210–1215. PMID: 14742578.
31. Rosenstein R, Nerz C, Biswas L, Resch A, Raddatz G, Schuster SC, Gätz F. Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol. 2009; 75:811–822. PMID: 19060169.
32. Ito T, Katayama Y, Hiramatsu K. Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrob Agents Chemother. 1999; 43:1449–1458. PMID: 10348769.
33. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000; 44:1549–1555. PMID: 10817707.
34. Sjöström JE, Löfdahl S, Philipson L. Transformation reveals a chromosomal locus of the gene(s) for methicillin resistance in Staphylococcus aureus. J Bacteriol. 1975; 123:905–915. PMID: 125746.
35. Kuhl SA, Pattee PA, Baldwin JN. Chromosomal map location of the methicillin resistance determinant in Staphylococcus aureus. J Bacteriol. 1978; 135:460–465. PMID: 249312.
36. Stewart GC, Rosenblum ED. Genetic behavior of the methicillin resistance determinant in Staphylococcus aureus. J Bacteriol. 1980; 144:1200–1202. PMID: 6254946.
37. Brown DF, Reynolds PE. Intrinsic resistance to beta-lactam antibiotics in Staphylococcus aureus. FEBS Lett. 1980; 122:275–278. PMID: 7202719.
38. Hartman BJ, Tomasz A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J Bacteriol. 1984; 158:513–516. PMID: 6563036.
39. Utsui Y, Yokota T. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1985; 28:397–403. PMID: 3878127.
40. Ubukata K, Yamashita N, Konno M. Occurrence of a beta-lactam-inducible penicillin-binding protein in methicillin-resistant staphylococci. Antimicrob Agents Chemother. 1985; 27:851–857. PMID: 3848294.
41. Matsuhashi M, Song MD, Ishino F, Wachi M, Doi M, Inoue M, Ubukata K, Yamashita N, Konno M. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J Bacteriol. 1986; 167:975–980. PMID: 3638304.
42. Song MD, Wachi M, Doi M, Ishino F, Matsuhashi M. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett. 1987; 221:167–171. PMID: 3305073.
43. Tesch W, Ryffel C, Strässle A, Kayser FH, Berger-Bächi B. Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2'. Antimicrob Agents Chemother. 1990; 34:1703–1706. PMID: 2285282.
44. Hürlimann-Dalel RL, Ryffel C, Kayser FH, Berger-Bächi B. Survey of the methicillin resistance-associated genes mecA, mecR1-mecI, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1992; 36:2617–2621. PMID: 1362343.
45. Suzuki E, Kuwahara-Arai K, Richardson JF, Hiramatsu K. Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical strains. Antimicrob Agents Chemother. 1993; 37:1219–1226. PMID: 8328773.
46. Ryffel C, Kayser FH, Berger-Bächi B. Correlation between regulation of mecA transcription and expression of methicillin resistance in staphylococci. Antimicrob Agents Chemother. 1992; 36:25–31. PMID: 1375449.
47. Hiramatsu K, Asada K, Suzuki E, Okonogi K, Yokota T. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett. 1992; 298:133–136. PMID: 1544435.
48. Kuwahara-Arai K, Kondo N, Hori S, Tateda-Suzuki E, Hiramatsu K. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP 2' production. Antimicrob Agents Chemother. 1996; 40:2680–2685. PMID: 9124822.
49. Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Hiramatsu K. Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001; 45:1323–1336. PMID: 11302791.
50. Hiramatsu K, Kondo N, Ito T. Genetic basis for molecular epidemiology of MRSA. J Infect Chemother. 1996; 2:117–129.
51. Stokes HW, Hall RM. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol Microbiol. 1989; 3:1669–1683. PMID: 2560119.
52. Hiramatsu K, Katayama Y, Yuzawa H, Ito T. Molecular genetics of methicillin-resistant Staphylococcus aureus. Int J Med Microbiol. 2002; 292:67–74. PMID: 12195737.
53. Chongtrakool P, Ito T, Ma XX, Kondo Y, Trakulsomboon S, Tiensasitorn C, Jamklang M, Chavalit T, Song JH, Hiramatsu K. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother. 2006; 50:1001–1012. PMID: 16495263.
54. Kondo Y, Ito T, Ma XX, Watanabe S, Kreiswirth BN, Etienne J, Hiramatsu K. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother. 2007; 51:264–274. PMID: 17043114.
55. Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, Daum RS, Hiramatsu K. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002; 46:1147–1152. PMID: 11897611.
56. Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother. 2004; 48:2637–2651. PMID: 15215121.
57. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob Agents Chemother. 2009; 53:4961–4967. PMID: 19721075.
58. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenover FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002; 40:4289–4294. PMID: 12409412.
59. Hisata K, Kuwahara-Arai K, Yamanoto M, Ito T, Nakatomi Y, Cui L, Baba T, Terasawa M, Sotozono C, Kinoshita S, Yamashiro Y, Hiramatsu K. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol. 2005; 43:3364–3372. PMID: 16000461.
60. Ruppé E, Barbier F, Mesli Y, Maiga A, Cojocaru R, Benkhalfat M, Benchouk S, Hassaine H, Maiga I, Diallo A, Koumaré AK, Ouattara K, Soumaré S, Dufourcq JB, Nareth C, Sarthou JL, Andremont A, Ruimy R. Diversity of staphylococcal cassette chromosome mec structures in methicillin-resistant Staphylococcus epidermidis and Staphylococcus haemolyticus strains among outpatients from four countries. Antimicrob Agents Chemother. 2009; 53:442–449. PMID: 19001111.
61. Hiramatsu K, Cui L, Kuroda M, Ito T. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol. 2001; 9:486–493. PMID: 11597450.
62. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001; 7:178–182. PMID: 11294701.
63. Zhang HZ, Hackbarth CJ, Chansky KM, Chambers HF. A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci. Science. 2001; 291:1962–1965. PMID: 11239156.
64. Hiramatsu K, Suzuki E, Takayama H, Katayama Y, Yokota T. Role of penicillinase plasmids in the stability of the mecA gene in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1990; 34:600–604. PMID: 2344167.
65. Wada A, Katayama Y, Hiramatsu K, Yokota T. Southern hybridization analysis of the mecA deletion from methicillin-resistant Staphylococcus aureus. Biochem Biophys Res Commun. 1991; 176:1319–1325. PMID: 2039513.
66. Lee SM, Ender M, Adhikari R, Smith JM, Berger-Bächi B, Cook GM. Fitness cost of staphylococcal cassette chromosome mec in methicillin-resistant Staphylococcus aureus by way of continuous culture. Antimicrob Agents Chemother. 2007; 51:1497–1499. PMID: 17283194.
67. Chatterjee SS, Chen L, Joo HS, Cheung GY, Kreiswirth BN, Otto M. Distribution and regulation of the mobile genetic element-encoded phenol-soluble modulin PSM-mec in methicillin-resistant Staphylococcus aureus. PLoS One. 2011; 6:e28781. PMID: 22174895.
68. Kaito C, Sekimizu K. Colony spreading in Staphylococcus aureus. J Bacteriol. 2007; 189:2553–2557. PMID: 17194792.
69. Kaito C, Omae Y, Matsumoto Y, Nagata M, Yamaguchi H, Aoto T, Ito T, Hiramatsu K, Sekimizu K. A novel gene, fudoh, in the SCCmec region suppresses the colony spreading ability and virulence of Staphylococcus aureus. PLoS ONE. 2008; 3:e3921. PMID: 19079549.
70. Hongo I, Baba T, Oishi K, Morimoto Y, Ito T, Hiramatsu K. Phenol-soluble modulin alpha 3 enhances the human neutrophil lysis mediated by Panton-Valentine leukocidin. J Infect Dis. 2009; 200:715–723. PMID: 19653829.
71. Kaito C, Saito Y, Nagano G, Ikuo M, Omae Y, Hanada Y, Han X, Kuwahara-Arai K, Hishinuma T, Baba T, Ito T, Hiramatsu K, Sekimizu K. Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog. 2011; 7:e1001267. PMID: 21304931.
72. Kaito C, Saito Y, Ikuo M, Omae Y, Mao H, Nagano G, Fujiyuki T, Numata S, Han X, Obata K, Hasegawa S, Yamaguchi H, Inokuchi K, Ito T, Hiramatsu K, Sekimizu K. Mobile genetic element SCCmec-encoded psm-mec RNA suppresses translation of agrA and attenuates MRSA virulence. PLoS Pathog. 2013; 9:e1003269. PMID: 23592990.
73. Luong TT, Ouyang S, Bush K, Lee CY. Type 1 capsule genes of Staphylococcus aureus are carried in a staphylococcal cassette chromosome genetic element. J Bacteriol. 2002; 184:3623–3629. PMID: 12057957.
74. Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, Barron A, Bason N, Bentley SD, Chillingworth C, Chillingworth T, Churcher C, Clark L, Corton C, Cronin A, Doggett J, Dowd L, Feltwell T, Hance Z, Harris B, Hauser H, Holroyd S, Jagels K, James KD, Lennard N, Line A, Mayes R, Moule S, Mungall K, Ormond D, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Sharp S, Simmonds M, Stevens K, Whitehead S, Barrell BG, Spratt BG, Parkhill J. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci U S A. 2004; 101:9786–9791. PMID: 15213324.
75. Zhang YQ, Ren SX, Li HL, Wang YX, Fu G, Yang J, Qin ZQ, Miao YG, Wang WY, Chen RS, Shen Y, Chen Z, Yuan ZH, Zhao GP, Qu D, Danchin A, Wen YM. Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol Microbiol. 2003; 49:1577–1593. PMID: 12950922.
76. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, Lin F, Lin J, Carleton HA, Mongodin EF, Sensabaugh GF, Perdreau-Remington F. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet. 2006; 367:731–739. PMID: 16517273.
77. Wu S, Piscitelli C, de Lencastre H, Tomasz A. Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri. Microb Drug Resist. 1996; 2:435–441. PMID: 9158816.
78. Tsubakishita S, Kuwahara-Arai K, Sasaki T, Hiramatsu K. Origin and molecular evolution of the determinant of methicillin resistance in staphylococci. Antimicrob Agents Chemother. 2010; 54:4352–4359. PMID: 20679504.
79. Hiramatsu K, Tsubakishita S, Matsuo M, Sasaki T. Molecular Evolution of MRSA 2010. In : 12th Western Pacific Congress on Chemotherapy and Infectious Diseases; 2011 Dec 2-5; Singapore. p. 11–18.
80. Tsubakishita S, Kuwahara-Arai K, Baba T, Hiramatsu K. Staphylococcal cassette chromosome mec-like element in Macrococcus caseolyticus. Antimicrob Agents Chemother. 2010; 54:1469–1475. PMID: 20086147.
81. García-Álvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, Walpole E, Brooks K, Pickard DJ, Teale C, Parkhill J, Bentley SD, Edwards GF, Girvan EK, Kearns AM, Pichon B, Hill RL, Larsen AR, Skov RL, Peacock SJ, Maskell DJ, Holmes MA. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011; 11:595–603. PMID: 21641281.
82. Shore AC, Deasy EC, Slickers P, Brennan G, O'Connell B, Monecke S, Ehricht R, Coleman DC. Detection of staphylococcal cassette chromosome mec type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011; 55:3765–3773. PMID: 21636525.
83. Harrison EM, Paterson GK, Holden MT, Morgan FJ, Larsen AR, Petersen A, Leroy S, De Vliegher S, Perreten V, Fox LK, Lam TJ, Sampimon OC, Zadoks RN, Peacock SJ, Parkhill J, Holmes MA. A Staphylococcus xylosus isolate with a new mecC allotype. Antimicrob Agents Chemother. 2013; 57:1524–1528. PMID: 23274660.
84. Schnellmann C, Gerber V, Rossano A, Jaquier V, Panchaud Y, Doherr MG, Thomann A, Straub R, Perreten V. Presence of new mecA and mph(C) variants conferring antibiotic resistance in Staphylococcus spp. isolated from the skin of horses before and after clinic admission. J Clin Microbiol. 2006; 44:4444–4454. PMID: 17005735.
85. Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist. 1996; 2:209–213. PMID: 9158761.
86. Williamson R, le Bouguénec C, Gutmann L, Horaud T. One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin. J Gen Microbiol. 1985; 131:1933–1940. PMID: 3850924.
87. el Kharroubi A, Jacques P, Piras G, Van Beeumen J, Coyette J, Ghuysen JM. The Enterococcus hirae R40 penicillin-binding protein 5 and the methicillin-resistant Staphylococcus aureus penicillin-binding protein 2' are similar. Biochem J. 1991; 280:463–469. PMID: 1747121.
88. Piras G, Raze D, el Kharroubi A, Hastir D, Englebert S, Coyette J, Ghuysen JM. Cloning and sequencing of the low-affinity penicillin-binding protein 3r-encoding gene of Enterococcus hirae S185: modular design and structural organization of the protein. J Bacteriol. 1993; 175:2844–2852. PMID: 8491705.
89. Mongkolrattanothai K, Boyle S, Murphy TV, Daum RS. Novel non-mecA-containing staphylococcal chromosomal cassette composite island containing pbp4 and tagF genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureus. Antimicrob Agents Chemother. 2004; 48:1823–1836. PMID: 15105141.
90. Wyke AW, Ward JB, Hayes MV, Curtis NA. A role in vivo for penicillin-binding protein-4 of Staphylococcus aureus. Eur J Biochem. 1981; 119:389–393. PMID: 7308191.
91. Henze UU, Roos M, Berger-Bächi B. Effects of penicillin-binding protein 4 overproduction in Staphylococcus aureus. Microb Drug Resist. 1996; 2:193–199. PMID: 9158759.
92. Yamakawa J, Aminaka M, Okuzumi K, Kobayashi H, Katayama Y, Kondo S, Nakamura A, Oguri T, Hori S, Cui L, Ito T, Jin J, Kurosawa H, Kaneko K, Hiramatsu K. Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study. J Infect Chemother. 2012; 18:406–409. PMID: 22033576.
93. Ryffel C, Strässle A, Kayser FH, Berger-Bächi B. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1994; 38:724–728. PMID: 8031036.
94. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol. 2003; 49:807–821. PMID: 12864861.
95. Kuroda M, Kuwahara-Arai K, Hiramatsu K. Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem Biophys Res Commun. 2000; 269:485–490. PMID: 10708580.
96. Aiba Y, Katayama Y, Hishinuma T, Murakami-Kuroda H, Cui L, Hiramatsu K. Mutation of RNA polymerase β-subunit gene promotes hetero-to-homo conversion of β-lactam resistance of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. [Submitted].
97. Kondo N, Kuwahara-Arai K, Kuroda-Murakami H, Tateda-Suzuki E, Hiramatsu K. Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control. Antimicrob Agents Chemother. 2001; 45:815–824. PMID: 11181367.
98. Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, Hiramatsu K. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob Agents Chemother. 2011; 55:4188–4195. PMID: 21746940.
99. Hiramatsu K, Igarashi M, Morimoto Y, Baba T, Umekita M, Akamatsu Y. Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature. Int J Antimicrob Agents. 2012; 39:478–485. PMID: 22534508.
100. Uchiyama I. MBGD: a platform for microbial comparative genomics based on the automated construction of orthologous groups. Nucleic Acids Res. 2007; 35:D343–D346. PMID: 17135196.
101. Uchiyama I. Hierarchical clustering algorithm for comprehensive orthologous-domain classification in multiple genomes. Nucleic Acids Res. 2006; 34:647–658. PMID: 16436801.
102. Clarke SR, Harris LG, Richards RG, Foster SJ. Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. Infect Immun. 2002; 70:6680–6687. PMID: 12438342.
103. Herron-Olson L, Fitzgerald JR, Musser JM, Kapur V. Molecular correlates of host specialization in Staphylococcus aureus. PLoS One. 2007; 2:e1120. PMID: 17971880.
104. Uchiyama I. Multiple genome alignment for identifying the core structure among moderately related microbial genomes. BMC Genomics. 2008; 9:515. PMID: 18976470.
105. Yarwood JM, McCormick JK, Paustian ML, Orwin PM, Kapur V, Schlievert PM. Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem. 2002; 277:13138–13147. PMID: 11821418.
106. Highlander SK, Hultén KG, Qin X, Jiang H, Yerrapragada S, Mason EO Jr, Shang Y, Williams TM, Fortunov RM, Liu Y, Igboeli O, Petrosino J, Tirumalai M, Uzman A, Fox GE, Cardenas AM, Muzny DM, Hemphill L, Ding Y, Dugan S, Blyth PR, Buhay CJ, Dinh HH, Hawes AC, Holder M, Kovar CL, Lee SL, Liu W, Nazareth LV, Wang Q, Zhou J, Kaplan SL, Weinstock GM. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 2007; 7:99. PMID: 17986343.
107. Fitzgerald JR, Monday SR, Foster TJ, Bohach GA, Hartigan PJ, Meaney WJ, Smyth CJ. Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens. J Bacteriol. 2001; 183:63–70. PMID: 11114901.
108. Ubeda C, Tormo MA, Cucarella C, Trotonda P, Foster TJ, Lasa I, Penadés JR. Sip, an integrase protein with excision, circularization and integration activities, defines a new family of mobile Staphylococcus aureus pathogenicity islands. Mol Microbiol. 2003; 49:193–210. PMID: 12823821.
109. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet. 2001; 357:1225–1240. PMID: 11418146.
110. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol. 2008; 190:300–310. PMID: 17951380.
111. Subedi A, Ubeda C, Adhikari RP, Penadés JR, Novick RP. Sequence analysis reveals genetic exchanges and intraspecific spread of SaPI2, a pathogenicity island involved in menstrual toxic shock. Microbiology. 2007; 153:3235–3245. PMID: 17906123.
112. Kwan T, Liu J, DuBow M, Gros P, Pelletier J. The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A. 2005; 102:5174–5179. PMID: 15788529.
Table 1
aClassified based on the integration site on the S. aureus chromosome. Correlated with the integrase phylogeny (see Figure 1B).
bThe name for the individual mobile element proposed by R. Novick [13]. Δsignifies that the element is a remnant. The name in parenthesis is the one originally described.
cStart, the first nucleoitde position of the left direct repeat (DR); End, the last nucleotide of the right DR; Size, in base pairs (bp); -, unknown because whole genome sequence data is unavailable.
dS. aureus resistance island carrying fusB [14].
eEuropean fusidic acid-resistant impetigo clone.